Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aurobindo Pharma: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
News Announcement

Aurobindo Pharma: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

04-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Confirmation of dispatch of letter to the shareholders who have not registered their email ids providing weblink for integrated Annual Report 2025-26.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds